Detalles de la búsqueda
1.
High PSA anxiety and low health literacy skills: drivers of early use of salvage ADT among men with biochemically recurrent prostate cancer after radiotherapy?
Ann Oncol
; 26(7): 1390-5, 2015 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-25926039
2.
A refined risk stratification scheme for clinical stage 1 NSGCT based on evaluation of both embryonal predominance and lymphovascular invasion.
Ann Oncol
; 26(7): 1396-401, 2015 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-25888612
3.
Incidence and determinants of 1-month mortality after cancer-directed surgery.
Ann Oncol
; 26(2): 399-406, 2015 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-25430935
4.
Determining optimal eluter design by modeling physical dose enhancement in brachytherapy.
Med Phys
; 2018 Jun 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-29905964
5.
The impact of comorbidity and PSA doubling time on the risk of death in men experiencing PSA failure following radiation therapy with or with androgen deprivation therapy for unfavorable-risk prostate cancer.
Prostate Cancer Prostatic Dis
; 20(2): 234-240, 2017 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-28117382
6.
Duration of the anti-androgen in men undergoing 6 months of an LHRH agonist and radiation therapy for unfavorable-risk prostate cancer and the risk of death.
Prostate Cancer Prostatic Dis
; 20(1): 79-84, 2017 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-27824043
7.
Which, when and why? Rational use of tissue-based molecular testing in localized prostate cancer.
Prostate Cancer Prostatic Dis
; 19(1): 1-6, 2016 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-26123120
8.
Role of interstitial radiotherapy in the management of clinically organ-confined prostate cancer: the jury is still out.
J Clin Oncol
; 14(1): 304-15, 1996 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-8558212
9.
Prostate-specific antigen failure despite pathologically organ-confined and margin-negative prostate cancer: the basis for an adjuvant therapy trial.
J Clin Oncol
; 15(4): 1465-9, 1997 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-9193341
10.
Clinical utility of the percentage of positive prostate biopsies in defining biochemical outcome after radical prostatectomy for patients with clinically localized prostate cancer.
J Clin Oncol
; 18(6): 1164-72, 2000 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-10715284
11.
Critical analysis of the ability of the endorectal coil magnetic resonance imaging scan to predict pathologic stage, margin status, and postoperative prostate-specific antigen failure in patients with clinically organ-confined prostate cancer.
J Clin Oncol
; 14(6): 1770-7, 1996 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-8656245
12.
Utilizing predictions of early prostate-specific antigen failure to optimize patient selection for adjuvant systemic therapy trials.
J Clin Oncol
; 18(18): 3240-6, 2000 Sep 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-10986056
13.
Pretreatment nomogram for prostate-specific antigen recurrence after radical prostatectomy or external-beam radiation therapy for clinically localized prostate cancer.
J Clin Oncol
; 17(1): 168-72, 1999 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-10458230
14.
Calculated prostate cancer volume greater than 4.0 cm3 identifies patients with localized prostate cancer who have a poor prognosis following radical prostatectomy or external-beam radiation therapy.
J Clin Oncol
; 16(9): 3094-100, 1998 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-9738580
15.
The association between race and treatment regret among men with recurrent prostate cancer.
Prostate Cancer Prostatic Dis
; 18(1): 38-42, 2015 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-25348256
16.
Prostate cancer volume adds significantly to prostate-specific antigen in the prediction of early biochemical failure after external beam radiation therapy.
Int J Radiat Oncol Biol Phys
; 35(2): 273-9, 1996 May 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-8635933
17.
Optimizing target coverage by dosimetric feedback during prostate brachytherapy.
Int J Radiat Oncol Biol Phys
; 48(4): 1245-9, 2000 Nov 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-11072185
18.
A method for determining a prostate-specific antigen cure after radiation therapy for clinically localized prostate cancer.
Int J Radiat Oncol Biol Phys
; 32(2): 473-7, 1995 May 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-7538502
19.
Optimizing patient selection for prostate monotherapy.
Int J Radiat Oncol Biol Phys
; 49(3): 673-7, 2001 Mar 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-11172948
20.
A clinical method for real-time dosimetric guidance of transperineal 125I prostate implants using interventional magnetic resonance imaging.
Int J Radiat Oncol Biol Phys
; 46(1): 207-14, 2000 Jan 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-10656394